Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations
Circulation: Genomic and Precision Medicine · 2024
DOI: 10.1161/circgen.123.004437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2024. Verfasst von Kui Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vanderbilt Epidemiology Center, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN (K.D., X.-O.S.,…. Hauptthemen laut MEDLINE: Coronary Disease, Metabolome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Metabolomics may reveal novel biomarkers for coronary heart disease (CHD). We aimed to identify circulating metabolites and construct a metabolite risk score (MRS) associated with incident CHD among racially and geographically diverse populations. METHODS: Untargeted metabolomics was conducted using baseline plasma samples from 900 incident CHD cases and 900 age-/sex-/race-matched controls (300 pairs of Black Americans, White Americans, and Chinese adults, respectively), which detected 927 metabolites with known identities among ≥80% of samples. After quality control, 896 case-control pairs remained and were randomly divided into discovery (70%) and validation (30%) sets within each race. In the discovery set, conditional logistic regression and least absolute shrinkage and selection operator over 100 subsamples were applied to identify metabolites robustly associated with CHD risk and construct the MRS. The MRS-CHD association was evaluated using conditional logistic regression and the C-index. Mediation analysis was performed to examine if MRS mediated associations between conventional risk factors and incident CHD. The results from the validation set were presented as the main findings. RESULTS: Twenty-four metabolites selected in ≥90% of subsamples comprised the MRS, which was significantly associated with incident CHD (odds ratio per 1 SD, 2.21 [95% CI, 1.62–3.00] after adjusting for sociodemographics, lifestyles, family history, and metabolic health status). MRS could distinguish incident CHD cases from matched controls (C-index, 0.69 [95% CI, 0.63–0.74]) and improve CHD risk prediction when adding to conventional risk factors (C-index, 0.71 [95% CI, 0.65–0.76] versus 0.67 [95% CI, 0.61–0.73]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Vanderbilt Epidemiology Center, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, TN (K.D., X.-O.S., L.L., W.Z., H.C., Q.C., D.Y.).
- Department of Medicine, Vanderbilt Translational and Clinical Cardiovascular Research Center and Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN (D.K.G.).
ORCID-Profile: Kui Deng, Deepak K Gupta, Xiao-Ou Shu, Loren Lipworth, Wei Zheng, Hui Cai, Qiuyin Cai, Danxia Yu
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Deng, K., Gupta, D. K., Shu, X. O., Lipworth, L., Zheng, W., Cai, H., Cai, Q., & Yu, D. (2024). Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.123.004437
Vancouver
Deng K, Gupta DK, Shu XO, Lipworth L, Zheng W, Cai H, et al. Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations. Circulation: Genomic and Precision Medicine. 2024. doi:10.1161/circgen.123.004437
BibTeX
@article{Deng2024,
author = {Deng, Kui and Gupta, Deepak K and Shu, Xiao-Ou and Lipworth, Loren and Zheng, Wei and Cai, Hui and Cai, Qiuyin and Yu, Danxia},
title = {Circulating Metabolite Profiles and Risk of Coronary Heart Disease Among Racially and Geographically Diverse Populations},
journal = {Circulation: Genomic and Precision Medicine},
year = {2024},
doi = {10.1161/circgen.123.004437}
}
EUVIMED